Epithelioid Sarcoma Research Fund

The Epithelioid Group / Honor Pages

The Epithelioid Sarcoma Group's mission is to be a catalyst in finding a cure for Epithelioid Sarcoma through research. This will be achieved through commitment and collaboration between the friends and families and the scientific community.

'Alone we can do so little; together we can do so much.'
-- Helen Keller 

  • $108,207

    Raised

  • $197,000

    Goal

  • 144

    Supporters

Recent Transactions

About Epithelioid Sarcoma Research Fund

*** IMPORTANT UPDATE *** 
We have drafted a detailed EpS road map that will get us to better treatments and hopefully a cure! In doing so, we determined that the first component in getting us there is FUNDING A SCIENTIST who will be dedicated and focused on EpS research and initial costs to do this is at $120,000 newly raised in 2023/2024. 

Having a dedicated researcher focused on finding better treatments and/or a cure for EpS is a HUGE opportunity for the EpS Community. One that will get us to the solutions we so desperately need.  

We thank you for your continued support. Please feel free to spread the word, and share this page with others as well.  

The Epithelioid Sarcoma Group (www.theEPSgroup.org) was founded in August 2018 at the cc-TDI nanocourse for Epithelioid Sarcoma (EpS). At this week-long course, 4 families determined that it was time to combine our common interest in finding a cure for EpS by forming a consortium. We saw the need for a group that could make headway in research by driving funding which enables the scientific community to focus efforts on the research for this rare cancer. For more information, contact epithelioidsarcomagroup@gmail.com.

August 2023 Update!
1.See the international research we supported, now published ( https://onlinelibrary.wiley.com/doi/full/10.1002/ctm2.961 )
  
2. Our new goals are (a) we're working hard on the basic science of tazemetostat action so that a second drug can be discovered, (b) we're going to fill the gap in EPS research tools by developing an EPS transgenic model. 

Facebook Comments